ʻO Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Maʻemaʻe >99.0% (HPLC) API Hale Kūʻai Kūlana Kiʻekiʻe
Hoʻolako i nā mea kikowaena pili i ka Sitagliptin Phosphate Monohydrate:
Sitagliptin API CAS 486460-32-6
Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid CAS 486460-00-8
Sitagliptin Triazole Hydrochloride CAS 762240-92-6
Sitagliptin Phosphate Monohydrate Intermediate CAS 486460-21-3
Inoa Kimia | ʻO Sitagliptin Phosphate Monohydrate |
Nā huaʻōlelo like | (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4- (2,4,5-trifluorophenyl)butan-1-hoʻokahi phosphate monohydrate |
Helu CAS | 654671-77-9 |
Kūlana Kūʻai | Ma ka waihona, hoʻonui ʻia a hiki i nā tona |
ʻĀpana Molekala | C16H20F6N5O6P |
Kaumaha Molecular | 523.3240802 |
Lae hehee | 202.0~204.0 ℃ |
Hiki i ka wai | Hiki i ka wai |
Hoʻololi kikoʻī | -18.0°~-23.0° (C=1, Wai) |
Brand | Kemika Ruifu |
'ikamu | Nā kikoʻī |
Ka nana aku | Keʻokeʻo a i ka pauka kristal keʻokeʻo |
ʻIke ʻia e HPLC | ʻO ka manawa paʻa o ka laʻana ua kūlike me ka maʻamau kuhikuhi |
IR-Infrared Spectrum | E kūlike ka IR Absorption Spectrum o ka hāpana me ka spectrum maʻamau |
Phosphate | Hoʻokō |
Maʻemaʻe / Kaʻina Hanana | >99.0% (HPLC ma ke kumu maloʻo) |
Waiwai (KF) | 3.3%~4.4% |
Koena ma ka Ignition | ≤0.20% |
Sulphate | ≤0.02% |
Klorida | ≤0.05% |
Ka haumia ʻo Chiral | <0.50% |
Na mea pili | |
Hoʻokahi haumia | <0.50% |
Huina paumaele | <1.0% |
Ethyl Acetate | <0.50% |
Nā Metala Kaumaha | <20ppm |
Kūlana hoʻāʻo | Kūlana ʻoihana |
Hoʻohana | Nā Kūwaena Lapaʻau |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.
ʻO Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9), he lāʻau hou no ka mālama ʻana i ka maʻi maʻi type 2.I ʻAukake 2009, ua ʻae ʻia ka lāʻau lapaʻau e ka European Union ma ke ʻano he lāʻau lapaʻau mua no ka mālama ʻana i ka maʻi diabetes type 2.ʻO Sitagliptin Phosphate ka mea mua i ʻae ʻia e ka FDA i ka dipeptidyl peptidase-IV inhibitor e hoʻohana ʻia i ka mālama ʻana i ka maʻi diabetes type 2 ma kahi mamao, ma lalo o ka inoa kālepa Januvia.ʻO Dipeptidylpeptidase Ⅳ (DPP-Ⅳ) wikiwiki a hoʻohaʻahaʻa i ka GLP-1, GLP-1, ʻo ia ka mea hoʻoulu maikaʻi loa o ka hana ʻana o ka insulin a me ka huna ʻana No laila, hiki i ka inhibition o DPP-IV ke hoʻonui i ka hana o ka endogenous GLP-1, a laila e hoʻonui ai i ke koko. ka pae o ka insulin, ma laila e hoʻemi a mālama i nā pae glucose koko i nā maʻi maʻi maʻi.I kēia manawa, ua hōʻoia ka lāʻau lapaʻau ʻo DPP-IV inhibitor kahi ʻano hou o ka lāʻau anti-diabetic, a hōʻike nā hopena lapaʻau he hopena hypoglycemic maikaʻi nā lāʻau.Ma muli o ka hana ʻana o ka GLP-1 i ka glucose i ka hoʻoikaika ʻana i ka hana ʻana a me ka huna ʻana o ka insulin, ʻaʻole hiki mai nā hopena ʻino maʻamau e like me ka hypoglycemia a me ka piʻi ʻana o ke kaumaha ma muli o ka hoʻohana ʻana i nā lāʻau antidiabetic.